Live Breaking News & Updates on Prnewswire Moleculin Biotech Inc

Stay updated with breaking news from Prnewswire moleculin biotech inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress

HOUSTON, May 16, 2024 /PRNewswire/ Moleculin Biotech, Inc., , a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today. ....

United States , Jenene Thomas , Wolframcm Dempke , Moleculin Biotech Inc , Prnewswire Moleculin Biotech Inc , European Chief Medical Officer , Moleculin Biotech , Transcription Modulator ,

Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update

Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United States , Michael Andreeff , Preliposomal Annamycin Lyophilizate , Jenene Thomas , Cytarabine Annara , Walter Klemp , Martin Tallman , Exchange Commission , Trademark Office , Development Program , Moleculin Biotech Inc , Prnewswire Moleculin Biotech Inc , American Association For Cancer Research , European Medicines Agency , Securities Exchange , Chief Executive Officer , Issue Notification , United States Patent , Reconstituting Liposomal Annamycin , New Drug Approval , Annamycin Scientific Advisory Board , Orphan Drug Designation , Fast Track , American Association , Cancer Research , Annamycin Remissions ,

Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin

Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , University Of Texas , Jenene Thomas , Liposomal Annamycin , Walter Klemp , Prnewswire Moleculin Biotech Inc , Securities Exchange , University Of Texas System Board Regents , Exchange Commission , Moleculin Biotech Inc , Trademark Office , Issue Notification , United States Patent , Reconstituting Liposomal , Texas System Board , Institutional Conflict , Pinterest Management , Moleculin Biotech , Transcription Modulator , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act ,

Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and Webcast

Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and Webcast
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Jenene Thomas , Moleculin Biotech Inc , Prnewswire Moleculin Biotech Inc , Moleculin Biotech Conference , Moleculin Biotech , Transcription Modulator ,

Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject Data

Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject Data
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Martin Tallman , J Paul Waymack , Cytarabine Annara , Jenene Thomas , Walter Klemp , Martins Tallman , Prnewswire Moleculin Biotech Inc , Roberth Lurie Comprehensive Cancer Center , Development Program , Northwestern University , Exchange Commission , Moleculin Biotech Inc , Securities Exchange , New Drug Approval , Chief Executive Officer , Annamycin Remissions , Composite Complete Remission , Remission Composite , Response Rate , Intent To Treat , Senior Chief Medical Officer , Comprehensive Cancer Center , Science Advisory , Moleculin Biotech , Transcription Modulator ,